Enhancement of Recombinant Human Tissue Plasminogen Activator Expression in CHO Cells using Matrix Attachment Region Containing Vectors in Combination with Promoter Activation Strategy

Authors
Azam Rahimpour
Behrouz Vaziri
Farzaneh Barkhordari
Leila Nematollahi
Ahmad Adeli
Fereidoun Mahboudi
Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran
Abstract
Objective: Development of high producing mammalian cell lines is a major bottleneck in manufacturing of recombinant therapeutic proteins. This study examines the effect of using the matrix attachment region from the human interferon beta gene in combination with promoter activation strategy with E1A 13S protein on human tissue plasminogen activator (t-PA) expression in Chinese hamster ovary (CHO) cells. Methods: The matrix attachment region was cloned in 3΄ and 5΄ flanking sides of the t-PA expression cassette in pTPA vector to generate pMTPA. After transfection of the cells with pTPA and pMTPA vectors, stable cell pools were developed and the t-PA expression level determined for each stable cell line. In the next step, E1A 13S expression plasmid was transfected to stable cell pools and t-PA titers were measured after 72 hours. Results: Integration of pTPA and pMTPA vectors in the CHO genome was confirmed by PCR analysis on genomic DNA of stable cell pools. Analysis of the t-PA expression level showed a three-fold enhancement in pMTPA transfected cells compared to pTPA-containing cells. t-PA expression was further enhanced up to 1771 U/ml by transient expression of E1A 13S in pMTPA stable cell pools. Conclusion: These results have shown that incorporation of matrix attachment region in an expression vector in combination with promoter activation can effectively enhance recombinant protein expression levels in CHO cells.
Keywords
Matrix attachment region
Promoter activation
tissue plasminogen activator
Chinese hamster ovary cell
[1]        Wurm FM. Production of recombinant protein therapeutics in cultivated mammalian cells. Nat Biotechnol 2004; 22(11): 1393-8.
[2]        Matasci M, Baldi L, Hacker DL, Wurm FM. The PiggyBac transposon enhances the frequency of CHO stable cell line generation and yields recombinant lines with superior productivity and stability. Biotechnol Bioeng 2011; 108(9): 2141-50.
[3]        Harraghy N, Buceta M, Regamey A, Girod PA, Mermod N. Using matrix attachment regions to improve recombinant protein production. Methods Mol Biol 2012; 801: 93-110.
[4]        Kwaks TH, Otte AP. Employing epigenetics to augment the expression of therapeutic proteins in mammalian cells. Trends Biotechnol 2006; 24(3): 137-42.
[5]        Bode J, Benham C, Knopp A, Mielke C. Transcriptional augmentation: modulation of gene expression by scaffold/matrix-attached regions (S/MAR elements). Crit Rev Eukaryot Gene Expr 2000; 10(1): 73-90.
[6]        Sjeklocha L, Chen Y, Daly MC, Steer CJ, Kren BT. β-globin matrix attachment region improves stable genomic expression of the Sleeping Beauty transposon. J Cell Biochem 2011; 112(9): 2361-75.
[7]        Recillas-Targa F, Valadez-Graham V, Farrell CM. Prospects and implications of using chromatin insulators in gene therapy and transgenesis. Bioessays 2004; 26(7): 796-807.
[8]        Kim JD, Yoon Y, Hwang HY, Park JS, Yu S, Lee J, Baek K, Yoon J. Efficient selection of stable chinese hamster ovary (CHO) cell lines for expression of recombinant proteins by using human interferon beta SAR element. Biotechnol Prog 2005; 21(3): 933-7.
[9]        Wang F, Wang TY, Tang YY, Zhang JH, Yang XJ. Different matrix attachment regions flanking a transgene effectively enhance gene expression in stably transfected Chinese hamster ovary cells. Gene 2012; 500(1): 59-62.
[10]     Zahn-Zabal M, Kobr M, Girod PA, Imhof M, Chatellard P, de Jesus M, Wurm F, Mermod N. Development of stable cell lines for production or regulated expression using matrix attachment regions. J Biotechnol 2001; 87(1): 29-42.
[11]     Girod PA, Zahn-Zabal M, Mermod N. Use of the chicken lysozyme 5' matrix attachment region to generate high producer CHO cell lines. Biotechnol Bioeng 2005; 91(1): 1-11.
[12]     Kim JM, Kim JS, Park DH, Kang HS, Yoon J, Baek K, Yoon Y. Improved recombinant gene expression in CHO cells using matrix attachment regions. J Biotechnol 2004; 107(2): 95-105.
[13]     Kwon RJ, Kim SK, Lee SI, Hwang SJ, Lee GM, Kim JS, Seol W. Artificial transcription factors increase production of recombinant antibodies in Chinese hamster ovary cells. Biotechnol Lett 2006; 28(1): 9-15.
[14]     Katakura Y, Seto P, Miura T, Ohashi H, Teruya K, Shirahata S. Productivity enhancement of recombinant protein in CHO cells via specific promoter activation by oncogenes. Cytotechnology 1999; 31(1-2): 103-9.
[15]     Pei R, Berk AJ. Multiple transcription factor binding sites mediate adenovirus E1A transactivation. J Virol 1989; 63(8): 3499-506.
[16]     Sanchez TA, Habib I, Leland Booth J, Evetts SM, Metcalf JP. Zinc finger and carboxyl regions of adenovirus E1A 13S CR3 are important for transactivation of the cytomegalovirus major immediate early promoter by adenovirus. Am J Respir Cell Mol Biol 2000; 23(5): 670-7.
[17]     Rouf SA, Moo-Young M, Chisti Y. Tissue-type plasminogen activator: characteristics, applications and production technology. Biotechnol Adv 1996; 14(3): 239-66.
[18]     Baruah DB, Dash RN, Chaudhari MR, Kadam SS. Plasminogen activators: a comparison. Vascul Pharmacol 2006; 44(1): 1-9.
[19]     Brezinsky SC, Chiang GG, Szilvasi A, Mohan S, Shapiro RI, MacLean A, Sisk W, Thill G. A simple method for enriching populations of transfected CHO cells for cells of higher specific productivity. J Immunol Methods 2003; 277(1-2): 141-55.
[20]     Bode J, Goetze S, Heng H, Krawetz SA, Benham C. From DNA structure to gene expression: mediators of nuclear compartmentalization and dynamics. Chromosome Res 2003; 11(5): 435-45.
[21]     Boulikas T. Nature of DNA sequences at the attachment regions of genes to the nuclear matrix. J Cell Biochem 1993; 52(1): 14-22.
[22]     Wang TY, Yang R, Qin C, Wang L, Yang XJ. Enhanced expression of transgene in CHO cells using matrix attachment region. Cell Biol Int 2008; 32(10): 1279-83.
[23]     Pennica D, Holmes WE, Kohr WJ, Harkins RN, Vehar GA, Ward CA, Bennett WF, Yelverton E, Seeburg PH, Heyneker HL, Goeddel DV, Collen D. Cloning and expression of human tissue-type plasminogen activator cDNA in E. coli. Nature 1983; 301(5897): 214-21.
[24]     Hemayatkar M, Mahboudi F, Majidzadeh-A K, Davami F, Vaziri B, Barkhordari F, Adeli A, Mahdian R, Davoudi N. Increased expression of recombinant human tissue plasminogen activator in Leishmania tarentolae. Biotechnol J 2010; 5(11): 1198-206.
Pathobiology Research
Volume 16, Issue 1
Summer 2013
Pages 11-21